Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$21.38
+1.71%
Mkt Cap $3.34B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (16 analysts)
$34.50
Range $25.00 – $40.00
Implied Upside
+61.4%
Consensus $34.50 vs current $21.38
NASDAQ·Healthcare·Biotechnology
$21.38
+1.71%
Mkt Cap $3.34B
Buy
14
Hold
0
Sell
0
Price Target (16 analysts)
$34.50
Range $25.00 – $40.00
+61.4%
Consensus $34.50 vs current $21.38